A compound termed ID#704946 was shown to inhibit MuRF1 E3 ligase activity in vitro and when translated to an in vivo wasting model following cardiac trauma, the compound inhibited skeletal muscle MuRF1 expression, proteolysis, contractile dysfunction, and fibre atrophy in skeletal muscle141. The gene discussed is TRIM63; the disease is injury.